Biodesix Inc 8-K Filing
Ticker: BDSX · Form: 8-K · Filed: Aug 15, 2024 · CIK: 1439725
| Field | Detail |
|---|---|
| Company | Biodesix Inc (BDSX) |
| Form Type | 8-K |
| Filed Date | Aug 15, 2024 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Biodesix Inc (ticker: BDSX) to the SEC on Aug 15, 2024.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (registered Common Stock, par value of $0.001 per share BDSX The Nasdaq Stock Mar).
How long is this filing?
Biodesix Inc's 8-K filing is 2 pages with approximately 505 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 505 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-08-14 21:22:05
Key Financial Figures
- $0.001 — registered Common Stock, par value of $0.001 per share BDSX The Nasdaq Stock Mar
Filing Documents
- d881327d8k.htm (8-K) — 26KB
- d881327dex991.htm (EX-99.1) — 28KB
- g881327ex99_1p10g1.jpg (GRAPHIC) — 287KB
- g881327ex99_1p11g1.jpg (GRAPHIC) — 258KB
- g881327ex99_1p12g1.jpg (GRAPHIC) — 236KB
- g881327ex99_1p13g1.jpg (GRAPHIC) — 196KB
- g881327ex99_1p14g1.jpg (GRAPHIC) — 165KB
- g881327ex99_1p15g1.jpg (GRAPHIC) — 283KB
- g881327ex99_1p16g1.jpg (GRAPHIC) — 444KB
- g881327ex99_1p17g1.jpg (GRAPHIC) — 388KB
- g881327ex99_1p18g1.jpg (GRAPHIC) — 402KB
- g881327ex99_1p19g1.jpg (GRAPHIC) — 227KB
- g881327ex99_1p1g1.jpg (GRAPHIC) — 479KB
- g881327ex99_1p20g1.jpg (GRAPHIC) — 335KB
- g881327ex99_1p21g1.jpg (GRAPHIC) — 368KB
- g881327ex99_1p22g1.jpg (GRAPHIC) — 405KB
- g881327ex99_1p23g1.jpg (GRAPHIC) — 279KB
- g881327ex99_1p24g1.jpg (GRAPHIC) — 298KB
- g881327ex99_1p2g1.jpg (GRAPHIC) — 735KB
- g881327ex99_1p3g1.jpg (GRAPHIC) — 444KB
- g881327ex99_1p4g1.jpg (GRAPHIC) — 230KB
- g881327ex99_1p5g1.jpg (GRAPHIC) — 301KB
- g881327ex99_1p6g1.jpg (GRAPHIC) — 267KB
- g881327ex99_1p7g1.jpg (GRAPHIC) — 276KB
- g881327ex99_1p8g1.jpg (GRAPHIC) — 244KB
- g881327ex99_1p9g1.jpg (GRAPHIC) — 197KB
- 0001193125-24-200857.txt ( ) — 10852KB
- bdsx-20240814.xsd (EX-101.SCH) — 3KB
- bdsx-20240814_lab.xml (EX-101.LAB) — 18KB
- bdsx-20240814_pre.xml (EX-101.PRE) — 11KB
- d881327d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits: No. Exhibit 99.1 Corporate Presentation of Biodesix, Inc., dated August 14, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 14, 2024 BIODESIX, INC. By: /s/ Robin Harper Cowie Name: Robin Harper Cowie Title: Chief Financial Officer